Filing Flows › Wave Life Sciences (WVE) › Q3 2026 › vs Q3 2025
Wave Life Sciences (WVE) Q3 2026 vs Q3 2025 (year over year)
Wave Life Sciences's revenue rose $5.5M (+73%) from $7.6M in Q3 2025 to $13.2M in Q3 2026.
Wave Life Sciences, Q3 2026: revenue $13.2M (+73% year over year), operating margin -502.0%, net loss $61.9M, operating cash flow −$60.1M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $13.2M | $7.6M | $5.5M | +73% |
| Other income, net | $4.1M | $2.5M | $1.6M | +65% |
| Net loss | $61.9M | $53.9M | $8.1M | +15% |
| Costs & expenses | $79.2M | $64.0M | $15.2M | +24% |
| Operating costs | $79.2M | $64.0M | $15.2M | +24% |
| Research & development | $53.8M | $45.9M | $8.0M | +17% |
| General & admin | $25.4M | $18.1M | $7.3M | +40% |
| Operating cash sources | $71.3M | $52.0M | $19.3M | +37% |
| Depreciation | $880K | $856K | $24K | +3% |
| Share-based compensation | $10.3M | $6.5M | $3.8M | +59% |
| Cash used in operations | $60.1M | $44.7M | $15.5M | +35% |
| Net loss absorbed | $61.9M | $53.9M | $8.1M | +15% |
| Working capital & other | $9.4M | −$1.9M | $11.3M | — |
Questions
How much did Wave Life Sciences's revenue grow year over year in Q3 2026?
Wave Life Sciences's revenue rose $5.5M (+73%) from $7.6M in Q3 2025 to $13.2M in Q3 2026.